Staff Members - Benha University
Assessment of C arcino embryonic Antigen-Related Cell Adhesion Molecules (CEACAM6) in Pancreatic Ductal Adenocarcinoma, A Combined Serum and Immunohistochemical Study
• 2015
Publication Information
Authors
MOSTAFA M. AMER, M.D.1; GHADA A. ABD EL-FATTAH, M.D.2; MOHEBAT H. GOUDA, M.D.2; RASHA M. EL-SAWI, M.D.2; EBADA M. SAEED, M.D.3 and AHMED ZEEDAN, M.D.4
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
International
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Background: Pancreatic cancer is a disease with an ex-tremely poor prognosis. Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) is emerging as an important determinant of the malignant phenotype in a range of cancers, including pancreatic cancer. Therefore, the aim of this study was to evaluate the potential involvement of CEACAM6 in the development, invasion and metastasis of pancreatic cancer cells.
Patients and Methods: This prospective study included 7 cases of chronic pancreatitis and 25 cases of pancreatic duct adenocarcinoma, which were collected from General Surgery Department, Faculty of Medicine, Benha University and Egyptian National Cancer Institute (NCI), in the period 2010- 2014. Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) immunohistochemical staining and soluble CEACAM6 were estimated in all cases and the pattern of expression in tissue was analyzed.
Results: Eighty eight percent of pancreatic ductal adeno-carcinoma cases were positive for CEACAM6, while only 14.3% of chronic pancreatitis were positive, which was statisti-cally significant (p
Patients and Methods: This prospective study included 7 cases of chronic pancreatitis and 25 cases of pancreatic duct adenocarcinoma, which were collected from General Surgery Department, Faculty of Medicine, Benha University and Egyptian National Cancer Institute (NCI), in the period 2010- 2014. Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) immunohistochemical staining and soluble CEACAM6 were estimated in all cases and the pattern of expression in tissue was analyzed.
Results: Eighty eight percent of pancreatic ductal adeno-carcinoma cases were positive for CEACAM6, while only 14.3% of chronic pancreatitis were positive, which was statisti-cally significant (p